In the next in our series, Dr Keith Hopcroft asks what is going on with this young male with recurrent urinary tract symptoms ...
7h
GlobalData on MSNVir enrols first subject in Phase III programme to assess CHD therapyThe programme includes the ECLIPSE 1 and ECLIPSE 2 Phase III trials, aiming to offer registrational data for regulatory ...
Building muscle isn’t just about nailing down a solid leg day and hammering your chest, back, and arms. You need the right ...
A recent study by Chinese scientists has revealed the intricate molecular machinery driving energy exchange within ...
The invasive nature of lipid biopsies has lead researchers to dedicate more efforts to unveiling noninvasive diagnostic ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
The one-time therapy appears to correct the mutation that causes the disease, known as Alpha-1 antitrypsin deficiency (AATD), ...
Twelve blood-based biomarkers related to inflammation, metabolism, liver and kidney function, as well as potential ...
2d
Asian News International on MSNShilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASHShilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the ...
Detailed price information for Natural Alternativ (NAII-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results